CClinicalTrials.gg
CompletedNCT02399787Updated Nov 10, 2020

Geneexpression as a Marker of Embryo Viability

An observational study in Infertility, sponsored by University of Aarhus. Completed at 1 site in Denmark. Per ClinicalTrials.gov, last updated 2020-11-10.

Sponsored by University of Aarhus · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
20
Sex
All
01

Study summary

The aim of the post doc project is investigate which genes regulate implantation in order to analyze specific proteins and microRNA in the spent culture media with the long-term goal of developing a non-invasive method of embryo assessment and selection. This will be achieved by conducting a targeted NGS analysis, based on list obtained from a non-published pilot study. When further validated by q-PCR, the expression of specific microRNAs known to influence the final list of genes will be analyzed in the spent culture media and the protein products of the genes recovered from the media will be quantified. The level of specific microRNAs and proteins will be related to aneuploidy and implantation potential. If the level of specific microRNA and/or proteins correlates with pregnancy, the study will form the basis for developing a clinical applicable precise method of improved embryo selection and thus improved IVF treatment.

02

Conditions studied

  • Infertility

Browse trials for

03

In context

Infertility

2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.

This study's enrollment of 20 is below the median of 200 across 714 observational studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Infertile women

Inclusion criteria

  • >5 oocytes retrieved

Exclusion criteria

Exclusion Criteria:

  • endometriosis
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No

Groups and cohorts

  • infertile patients

    Infertile patients with more than 5 oocytes retrieved and no endometriosis

    Other: blastocyst biopsy

Interventions

  • Otherblastocyst biopsy

    Performed on day 5

06

What researchers measure

Primary outcomes

  1. gene expression

    the expression of specific microRNAs known to influence the final list of genes will be analyzed in the spent culture media and the protein products of the genes recovered from the media will be quantified. The level of specific microRNAs and proteins will be related to aneuploidy and implantation potential. If the level of specific microRNA and/or proteins correlates with pregnancy, the study will form the basis for developing a clinical applicable precise method of improved embryo selection and thus improved IVF treatment

    Time frame: 2 years

07

Study locations

1 site
  • The Fertility Clinic, Aarhus University Hospital, Skejby
    Aarhus, 8200, Denmark
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 10, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02399787
Lead sponsor
University of Aarhus
Collaborators
Aarhus University Hospital
Responsible party
Kirstine Kirkegaard (post doc, University of Aarhus) — Principal investigator
First posted
Mar 26, 2015
Start date
Apr 2015
Primary completion
May 1, 2020
Completion
May 1, 2020
Last update
Nov 10, 2020

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion